(Q41386792)

30 September 2017

title

Differential effects of prostaglandin E1 and prostaglandin E2 on growth and differentiation of murine myeloid leukemic cell line, M1. (English)

1 reference

30 September 2017

1 reference

1 reference

1 reference

Sawamura H

1

1 reference

30 September 2017

Hayashi H

series ordinal

2

1 reference

30 September 2017

Onozaki K

series ordinal

3

1 reference

30 September 2017

publication date

1 January 1995

1 reference

Microbiology and Immunology

30 September 2017

published in

1 reference

30 September 2017

volume

39

1 reference

30 September 2017

issue

10

1 reference

30 September 2017

page(s)

809-815

1 reference

Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Prostaglandin E2 selectively increases interferon gamma receptor expression on human CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Regulation of the immune response by prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Thromboxane, prostaglandin and leukotriene receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Differentiation of a cell line of myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Cyclic AMP mimics IL-1 action in augmenting the differentiation of a mouse myeloid leukemic cell line (M1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Lymphocyte hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Prostaglandins and thromboxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Interleukin‐1 up‐regulates transcription of its own receptor in a human fibroblast cell line TIG‐1: role of endogenous PGE2 and cAMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

Prostaglandins modulate macrophage Ia expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1995.TB03261.X

10.1111/J.1348-0421.1995.TB03261.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference